Cerulean Pharma, Inc. (CERU) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Date: May 18, 2015
Pages: 36
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: C499694BE07EN
Leaflet:

Download PDF Leaflet

Cerulean Pharma, Inc. (CERU) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary

Cerulean Pharma, Inc. (Cerulean) is a biopharmaceutical company. It specializes in the development of dynamically tumor-targeted nanopharmaceuticals. The company designs and develops nanotechnology-based therapeutics for diseases in the fields of oncology, cardiovascular, autoimmune and inflammatory. Its nanopharmaceutical platform creates patent-protectable new chemical entities (NCEs) by chemically conjugating active pharmaceutical ingredients inside nanoparticles. Cerulean’s pipeline products include CRLX101, CRLX301 and RNA delivery program. The company has licensed nanoparticle-based technology from Massachusetts Institute of Technology. It develops therapeutics based on multi-compartmental nanoparticle. The company’s RNA delivery program has produced a variety of RNA-containing nanopharmaceuticals. It was formerly known as Tempo Pharmaceuticals, Inc. Cerulean is headquartered in Cambridge, Massachusetts, the US.

Cerulean Pharma, Inc. (CERU) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
Cerulean Pharma, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Cerulean Pharma, Inc., Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015
Cerulean Pharma, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Cerulean Pharma, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
Cerulean Pharma, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015
Cerulean Pharma, Inc., Pharmaceuticals & Healthcare, Deal Details
Venture Financing
Cerulean Pharma Secures USD15 Million from Hercules Technology Growth Capital
Cerulean Pharma Raises US$13 Million In Venture Financing
Cerulean Pharma Secures US$15 Million In Series D Financing
Cerulean Pharma Secures US$24 Million In Series C Financing
Cerulean Pharma Secures US$1.5 Million In Venture Financing
Cerulean Pharma Raises US$5 Million In Venture Financing
Cerulean Pharma Raises US$10 Million In Series B-1 Financing Round
Cerulean Pharma Raises US$20 Million In Venture Financing Round
Partnerships
Cerulean Pharma Enters into Research Agreement with GOG Foundation
Licensing Agreements
Cerulean Pharma Enters Into Licensing Agreement With Calando Pharma
Equity Offering
Cerulean Pharma Raises USD40 Million in Public Offering of Shares
Cerulean Pharma Raises USD1 Million in Private Placement of Shares
Cerulean Pharma Completes Underwriters Exercise Of Over-Allotment Option Of IPO For US$67 Million
Cerulean Pharma, Inc. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES
Cerulean Pharma, Inc., Pharmaceuticals & Healthcare, Key Facts, 2014
Cerulean Pharma, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Cerulean Pharma, Inc., Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015
Cerulean Pharma, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Cerulean Pharma, Inc., Deals By Therapy Area, 2009 to YTD 2015
Cerulean Pharma, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015
Cerulean Pharma Secures USD15 Million from Hercules Technology Growth Capital
Cerulean Pharma Raises US$13 Million In Venture Financing
Cerulean Pharma Secures US$15 Million In Series D Financing
Cerulean Pharma Secures US$24 Million In Series C Financing
Cerulean Pharma Secures US$1.5 Million In Venture Financing
Cerulean Pharma Raises US$5 Million In Venture Financing
Cerulean Pharma Raises US$10 Million In Series B-1 Financing Round
Cerulean Pharma Raises US$20 Million In Venture Financing Round
Cerulean Pharma Enters into Research Agreement with GOG Foundation
Cerulean Pharma Enters Into Licensing Agreement With Calando Pharma
Cerulean Pharma Raises USD40 Million in Public Offering of Shares
Cerulean Pharma Raises USD1 Million in Private Placement of Shares
Cerulean Pharma Completes Underwriters Exercise Of Over-Allotment Option Of IPO For US$67 Million
Cerulean Pharma, Inc., Key Competitors
Cerulean Pharma, Inc., Key Employees

LIST OF FIGURES
Cerulean Pharma, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Cerulean Pharma, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Cerulean Pharma, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Cerulean Pharma, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
Cerulean Pharma, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Cerulean Pharma, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Cerulean Pharma, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Cerulean Pharma, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
Skip to top


Ask Your Question

Cerulean Pharma, Inc. (CERU) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: